Table 9.

Summary of zinc(II) complexes coordinated to O N O ligands with better IC₅₀ values (μM) in different cell lines.

Compound	Metal geometry	Exposure time [h]	Cell lines	IC50 value [μM]	Main feature	Ref.
Zn‐06	Octahedral	48	HeLa MCF‐7 A‐2780 V‐79	4.58±1.0 3.04±1.2 1.73±0.4 4.06±0.55	Anticancer activity depends on the presence of the co‐ligand, in this case diphphen	[102]
Zn‐10		NR	HeLa K‐562	14.28 25.07	Anticancer activity depends on the nuclearity and geometry of the complexes	[105]